U.S. Army and France's Sanofi combine work on Zika vaccine

PARIS — Pharmaceutical giant Sanofi says it is joining efforts with U.S. Army researchers to speed up development of a potential Zika vaccine.

France-based Sanofi SA said in a statement Wednesday that the Walter Reed Army Institute of Research will transfer its Zika vaccine technology to Sanofi Pasteur, the company's vaccine arm. Sanofi views the agreement as "opening the door for a broader collaboration with the U.S. government."

Financial details were not disclosed.

Vaccine development usually takes years. Sanofi made the first vaccine shot against dengue — which is related to Zika — but it required 20 years of development and $1 billion. Sanofi and U.S. researchers are trying to leverage experience with related viruses to accelerate work on Zika amid the current outbreak of the mosquito-borne virus across the Americas.

In Other News

January 6 convict asks for light sentence in order to remain in Navy

An active-duty service member convicted in the Jan. 6, 2021, attack urged a judge for a light sentence in order to remain in the Navy.

Agreement helps military spouses keep federal jobs in overseas moves

Here's how an agreement between the Pentagon and State Department will help federally employed military spouses move their jobs overseas in a PCS.

Navy ship underway for Gaza pier mission suffers fire, returns to US

The cargo ship 2nd Lt. John P. Bobo suffered a fire in its engine room Thursday, forcing it to return to Florida, the Navy said.

VA to largely end animal testing on dogs, cats within two years

The Department of Veterans Affairs is slated to largely end testing on dogs, cats and nonhuman primates within the next two years.

Biden says uncle’s remains never found during WWII due to cannibals

While the claim contradicts the DPAA report about his uncle's fate, Biden's comments on cannibalism in the region during WWII are not far off.

Load More